http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2013DE01007-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a24ed3ad6bb32bc3e6e76bab91e20b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80a00150c567a1830c8f0f509d6e3139 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b52ef6ea26f0365b3bbd998fce6c505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5288c1339d820aaf7bd23df0e53d5e30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58b17738061ed9348d42f8213100da1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24ff4f91ba7cee3b3af241b9cc0f247c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 |
| filingDate | 2013-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0aeaa7c7544f6cb5e3c9bd28e00dc57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b5cefc0fa1551a06fe0f3db12f2d6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd393e2c6fd0d21dbfcaaedb4f15361 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac5c47796492a0cadaab7946d6af6be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dad7e727a6a5fb27cb2911e77264283c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e10c0b208a9475e17f76b67fc1fc0e76 |
| publicationDate | 2015-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IN-2013DE01007-A |
| abstract | The present invention relates to an herbal extract Solanum khasianum, Clarke. for anti-inflammatory, anthelmintic and antimicrobial activities. The ethanolic extract of Solanum khasianum, Clarke. was tested for anti-inflammatory, anthelmintic and antimicrobial activities. Anti-inflammatory activity was tested in carrageenan induced rat hind paw edema method and cotton pellet granuloma at two dose level of 200 mg/kg and 400 mg/kg respectively, Diclofenac sodium (100 mg/kg) was used as reference standard. The anti-inflammatory activity of the extract was compared with standard and control. The anthelmintic activity of the extract was tested on Tape worm, Liver fluke, Thread worm and Hook worm using two different concentrations, 100 mg/ml and 200 mg/ml. Time taken for the paralysis and death was noted and compared with the standard drug. Piperazine citrate 15 mg/ml was used as the standard. Antimicrobial activity was done by agar cup plate method at a concentration of 5 mg/ml of the extract, using fluconozole as the standard. The organisms used were Aspergillus niger and Candida albicans and the zone of inhibition was determined. |
| priorityDate | 2013-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.